天津嵘元智能 (Tianjin Rongyuan Intelligent Technology)
Tianjin, China
天津嵘元智能科技有限公司 is described by the Nankai District government as the vehicle for Prof. Duan Feng’s team at Nankai University, set up in April 2023 in the Tiankai park. The district says it works on an endovascular BCI, domestic neurovascular devices for acute stroke, and a rehabilitation robot. The district reports a first-in-human endovascular BCI trial in a 67-year-old man with left-side paralysis after stroke (August 2025, government news page; the company’s own claims are not separately sourced).
- Nankai District government news (Chinese): https://www.tjnk.gov.cn/NKQZF/XXDT856/nkyw/202508/t20250824_7118437.html
- Registry record naming the company as funder: ChiCTR2400093125, leader Lin Zhixiong, Fujian Sanbo Funeng Brain Hospital, 1 subject, non-randomized.
Device entries
No device sheet yet. The closest existing entry for an endovascular BCI is the Stentrode sheet: Stentrode. Whether the Rongyuan “type A sensor” shares that design is not stated in the sources read.
Limits
Founding date and trial claims come from a government news page and the registry. No company website, NMPA filing or financing record was read. The overview page lists this company with the registry trial: China overview.